Federal Contractor Profile
Regeneron Pharmaceuticals INC
Federal contracting record: $6.6B obligated across 12 awards from 3 agencies, FY 2016–2026.
$6.6B
Total Obligated
12
Award Records
3
Agencies Served
3
NAICS Codes
Company Profile
Parent UEI (Unique Entity Identifier)
N3F9MH7E6HD6
CAGE Code
544P9
Address
777 OLD SAW MILL RIVER RD, TARRYTOWN, NY, 105916717
First Federal Award
Oct 21, 2015
Most Recent Award
Jul 30, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- Department of Defense$5.6B
84.8% of total obligations
- Department of Health and Human Services$1.0B
15.2% of total obligations
- Department of Veterans Affairs$642K
0.0% of total obligations
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Jul 30, 2026 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $2.7M → |
| Aug 21, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $326M → |
| Nov 24, 2021 | Department of Veterans Affairs241-NETWORK CONTRACT OFFICE 01 (36C241) | 325412 | EVKEEZA DRUG | $494K → |
| Sep 14, 2021 | Department of DefenseW6QK ACC-APG NATICK | 325414 | PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC. | $2.9B → |
| Sep 8, 2021 | Department of Veterans Affairs241-NETWORK CONTRACT OFFICE 01 (36C241) | 325412 | EVKEEZA | $148K → |
| Jan 12, 2021 | Department of DefenseW6QK ACC-PICA | 325414 | PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC. | $2.6B → |
| Jul 25, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $345M → |
| Jun 18, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $54M → |
| Jun 15, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $85M → |
| Apr 29, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $9.2M → |
| Apr 23, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $47M → |
| Mar 21, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $93M → |
| Jan 31, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $5.8M → |
| Sep 25, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $23M → |
| Sep 12, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $20M → |
| May 22, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $132M → |
| Aug 13, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $53M → |
| May 9, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $26M → |
| Feb 13, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $28M → |
| Sep 28, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $40M → |
| Sep 21, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $19M → |
| May 31, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF | $15M → |
| Nov 23, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $7.2M → |
| Aug 12, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $1.8M → |
| Oct 21, 2015 | Department of Health and Human ServicesOFF ASST SEC ADM AND MGMT | 541711 | REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF | $2.4M → |
Want to win work like Regeneron Pharmaceuticals INC?
Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.